Skip to main content

Table 2 Resistance to additional drugs among RIF-resistant TB patients

From: Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Characteristics

Pre-Xpert

N = 28

Post-Xpert

N = 30

p *

Resistance to any additional FLD

   

0.05

Yes

28 (100%)

18 (60%)

 

No

0

4 (13%)

 

Missing

0

8 (27%)

 

Resistance to 4 FLD

   

0.02

Yes

21 (75%%)

8 (27%%)

 

No

7 (25%)

14 (46%)

 

Missing

0

8 (27%)

 

Resistance to any SLD

   

0.8

Yes

13 (46%)

10 (33%)

 

No

15 (54%)

12 (40%)

 

Missing

0

8 (27%)

 
  1. * Chi-square p-values